Overview

CCN NSW is pleased to extend a warm invitation to members for a special webinar event on Electroconvulsive Therapy (ECT), offering a unique opportunity to engage with leading knowledge and clinical insights.

Electroconvulsive therapy (ECT) remains the oldest and most effective treatment for severe or difficult-to-treat neuropsychiatric disorders, although is often underutilised due to issues including access, concerns regarding cognitive effects and stigma. During training and in clinical practice, neuropsychologists generally are not educated or regularly exposed to clients who receive ECT, which could play a role in perpetuating misunderstandings regarding treatment and its neuropsychological effects, and practitioners perhaps to even question, e.g., why is this still being done?

This webinar will aim to cover the basics of modern ECT practice, including describing what it involves and how it is administered, who it is administered to, treatment mechanisms and acute and longitudinal neuropsychological effects. The webinar will further explore how different treatment and patient factors in turn affect neuropsychological outcomes, which have relevance for interpretation of subjectively reported and objectively measured cognitive changes potentially attributed to treatment. Last, the webinar will cover recent advancements in treatment monitoring using brief cognitive screening instruments across ECT treatment and their role in optimising patient outcomes, illustrating ever increasing role of neuropsychology in ensuring patients gain maximal clinical benefits from treatment.

Learning Outcomes

• Improved understanding of modern best practice ECT
• Overview of short and longer term neuropsychological effects
• Overview of what treatment and patient factors affect neuropsychological outcomes
• Improved understanding of the role of cognitive monitoring in improving patient outcomes

Presenter(s)

Dr. Donel Martin

About the presenter(s)

This webinar will be led by Dr. Donel Martin a clinical academic researcher based at the Black Dog Institute and University of New South Wales and practicing Senior Clinical Neuropsychologist. Dr. Martin has a Ph.D in psychology and a Masters in Clinical Neuropsychology. He is the Head of the Neurocognition team at the Black Dog Institute, which investigates the cognitive and emotional effects of interventional treatments for psychiatric disorders, including ketamine, psilocybin, non-invasive brain stimulation and ECT. He has been a researcher for over 18 years, published >150 peer reviewed papers and 13 book chapters, and been cited over 5000 times. In the field of Psychiatry/Psychology he is in the top 1% of highly cited authors.

Notes

Target Audience

This event is tailored for clinical neuropsychologists and clinicians seeking to develop a deeper and more nuanced understanding of Electroconvulsive Therapy (ECT), including its evolving role in modern practice.

Please note:

• This is a Member Groups event. All communication will be sent to the registrants’ registered email address. This includes event reminders with details (such as the Zoom link) and any pre-event or post-event resources, if provided by the facilitators.
• A post-event email will be sent within two weeks of the event’s completion to each registrant’s registered email address. This email will include the CPD certificate, and any additional resources shared during the session.

Duration of Access

This event will not be recorded. 

CPD

It is up to attendees to assess and determine how learning from this event aligns with the requirements of their learning plan. The providers accordingly do not make any representation that the event counts towards attendees’ CPD learning requirements. If an attendee determines themselves that the learning they complete aligns to their learning plan, then they can decide to count those hours towards their CPD requirements for the registration cycle.

The information in this presentation has been prepared in good faith and for educational purposes only. Therefore, the information is general in nature and should not be relied upon in the treatment of any condition and you should seek your own independent professional and/or legal advice concerning any specific issue. The APS accepts no responsibility for any errors, omissions or decisions relating to the information. The content should not be reproduced without permission or unless permitted by law.

If you are experiencing registration difficulties please contact APS Events Support.